Who owns Neuphoria Therapeutics Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of NEUP from SEC Form 13F filings across 22 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 22 institutions disclosed 2.0M shares of Neuphoria Therapeutics Inc. worth $8.5M — about 36.8% of shares outstanding; the largest disclosed holder is Lynx1 Capital Management LP. Source: SEC Form 13F filings, parsed by EvidInvest.
22
13F holders
$8.5M
value, 2026 filers
36.8%
of shares outstanding (2.0M sh)
8
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of NEUP's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | Lynx1 Capital Management LP | 875,328 | $3.8M | 0.8% | 16.2% | 0.0% |
| 2 | AdvisorShares Investments LLC | 252,909 | $1.1M | 0.1% | 4.7% | +62.8% |
| 3 | VANGUARD CAPITAL MANAGEMENT LLCNEW | 173,488 | $758,143 | 0.0% | 3.2% | new |
| 4 | Shay Capital LLC | 155,822 | $680,942 | 0.0% | 2.9% | +3.2% |
| 5 | Balyasny Asset Management L.P. | 142,228 | $621,536 | 0.0% | 2.6% | 0.0% |
| 6 | CITADEL ADVISORS LLC | 72,559 | $317,083 | 0.0% | 1.3% | +275.4% |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | 49,516 | $216,384 | 0.0% | 0.9% | -4.8% |
| 8 | Ikarian Capital, LLC | 47,443 | $207,326 | 0.0% | 0.9% | 0.0% |
| 9 | VANGUARD FIDUCIARY TRUST CONEW | 33,806 | $147,732 | 0.0% | 0.6% | new |
| 10 | ADAR1 Capital Management, LLC | 30,000 | $131,100 | 0.0% | 0.6% | 0.0% |
| 11 | FNY Investment Advisers, LLC | 26,500 | $115 | 0.0% | 0.5% | 0.0% |
| 12 | RENAISSANCE TECHNOLOGIES LLCNEW | 25,500 | $111,435 | 0.0% | 0.5% | new |
| 13 | XTX Topco LtdNEW | 23,089 | $100,899 | 0.0% | 0.4% | new |
| 14 | HRT FINANCIAL LPNEW | 22,865 | $99 | 0.0% | 0.4% | new |
| 15 | JANE STREET GROUP, LLCNEW | 14,903 | $65,126 | 0.0% | 0.3% | new |
| 16 | BOOTHBAY FUND MANAGEMENT, LLC | 14,000 | $61,180 | 0.0% | 0.3% | 0.0% |
| 17 | COMMONWEALTH EQUITY SERVICES, LLC | 11,222 | $49,040 | 0.0% | 0.2% | 0.0% |
| 18 | NORTHERN TRUST CORPNEW | 10,610 | $46,366 | 0.0% | 0.2% | new |
| 19 | Merck & Co., Inc. | 10,027 | $43,818 | 0.0% | 0.2% | 0.0% |
| 20 | UBS Group AG | 2,117 | $9,251 | 0.0% | 0% | -8.6% |
| 21 | MORGAN STANLEY | 58 | $254 | 0.0% | 0% | 0.0% |
| 22 | Caitong International Asset Management Co., LtdNEW | 3 | $13 | 0.0% | 0% | new |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.